136 results
Page 4 of 7
8-K
EX-1.1
ovvipv8z6 xk
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
dz8te29tvdp g4s
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
2kevu78apd xym
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-10.1
k4o18 nw2p9
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.4
164ug
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
86b 4m10to
15 May 19
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
8:11am
CORRESP
ukp5xmvrylcxhiybdy8f
3 Dec 18
Correspondence with SEC
12:00am
CORRESP
a3qjpwurisc9l1khg1
18 Oct 18
Correspondence with SEC
12:00am